+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Drug Delivery System"

From
From
From
From
From
From
From
From
From
From
From
From
From
Pharmaceutical Drug Delivery Market Report 2025 - Product Thumbnail Image

Pharmaceutical Drug Delivery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Advanced Drug Delivery Systems Market Report 2025 - Product Thumbnail Image

Advanced Drug Delivery Systems Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pulmonary Drug Delivery Devices Global Market Report 2024 - Product Thumbnail Image

Pulmonary Drug Delivery Devices Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
Loading Indicator

Targeted Drug Delivery System (TDDS) is a specialized area within the broader pharmacological field of Drug Delivery. TDDS aims to direct medication to specific cells, tissues, or organs, thereby increasing the concentration of the drug at the intended site of action while minimizing its presence in the rest of the body. This method potentially reduces side effects and enhances treatment efficacy. The market for these systems encompasses a wide range of technologies and platforms, such as nanoparticles, liposomes, and biodegradable polymers designed to release pharmaceutical compounds in a controlled manner. The field has been propelled by advances in biotechnology, nanotechnology, and molecular biology, which have contributed to the development of novel targeted drug delivery mechanisms. These include antibodies, receptor-mediated delivery systems, and gene-delivery vectors. TDDS is used in addressing various medical conditions, with cancer therapy being a particularly active area due to the need for precise drug delivery to tumor cells. Several companies specialize in the research and development of Targeted Drug Delivery Systems, contributing to the maturation of this market. Some notable players in the field include Alkermes, BIND Therapeutics, DEPArray Technology, Genentech, Immunomedics, Inc., and Kite Pharma. These companies have a diverse product portfolio of targeted delivery technologies and are engaged in the development of innovative treatments for a wide range of diseases, striving to improve therapeutic outcomes and patient quality of life. Show Less Read more